Investigating Leeds.

Leeds first because it's a big, busy market: a city region of well over half a million people, served by high-street pharmacies, online clinics and (inevitably) sellers who'd rather you didn't check either. Mounjaro, Wegovy, the Wegovy pill and Foundayo are all prescription-only medicines. The law and the GPhC's standards put strict limits on how POMs can be promoted and supplied, and this investigation is about who in Leeds is staying inside those limits, and who isn't.

The tactics we're looking for

Most pharmacies do this properly. Some don't, and the dodgy end of the market has a recognisable playbook. In Leeds we're actively checking for:

• Rubber-stamp consultations: questionnaires approved in seconds with no real prescriber review, no BMI verification and no questions asked, which is how POMs end up with people they can harm.
• Pressure selling of POMs: countdown timers, "only 3 left at this price", upsell funnels and discount codes pushed harder than the clinical questions. Prescription medicines aren't trainers; selling them like trainers is a red flag.
• Misleading advertising: promoting prescription-only medicines to the public in ways the Human Medicines Regulations 2012 and ASA rulings don't allow, including "lose 20 pounds fast" style claims attached to named POMs.
• Fake and incentivised reviews: suspicious bursts of five-star reviews, review-gating, or "discount for a good review" schemes that make a shaky operator look loved.
• Hidden ownership: websites that don't name their legal entity, company number or registered office, comparison sites that secretly funnel to pharmacies their owners run, and "independent" rankings that aren't.
• Phantom registrations: claiming GPhC registration that belongs to a different company, or borrowing a superintendent's name without permission.
• Bait pricing: advertising a headline price that doesn't exist at checkout once "consultation", "prescribing" and "delivery" fees are bolted on.

What we're examining

• Every company we can identify selling or supplying weight-loss medication into Leeds, online-first and bricks-and-mortar alike.
• GPhC registration status for each, with the live register entry linked where one exists.
• Whether each website names its legal entity, company number and registered office, and what Companies House says about it.
• Consultation and prescribing standards, advertising behaviour, and each provider's real customer record.

What the evidence is already showing

Evidence gathering is under way, and a pattern is emerging clearly enough to state now, in general terms, with the named detail held back until each finding is fully documented:

• Some pharmacy groups are operating networks of websites into Leeds without declaring the connection. Different brands, different designs, different "about us" pages, but the same companies, the same premises, sometimes the same prescribers behind them. Where sites share an owner and don't say so, patients comparing "independent" options are being misled.
• Unlawful trading disclosures. UK law requires business websites to display their registered name, company number and registered office, the Electronic Commerce (EC Directive) Regulations 2002 and the Company, Limited Liability Partnership and Business (Names and Trading Disclosures) Regulations 2015 are not optional. Sites selling into Leeds have been logged that hide or omit this information entirely, which makes the operator harder to trace, report or complain about. Hiding who you are is not something a well-run pharmacy needs to do.
• Undeclared conflicts of interest. "Comparison" and "review" websites presenting themselves as independent while funnelling patients to pharmacies run by the same people, without declaring it. The Consumer Protection from Unfair Trading Regulations 2008 and the Digital Markets, Competition and Consumers Act 2024 treat misleading omission of this kind as unlawful, and regulators expect commercial relationships to be declared.
• Advertising that pushes the POM line. Promotion of prescription-only medicines to the public sits under strict limits in the Human Medicines Regulations 2012, enforced by the MHRA and policed through ASA rulings. Material logged in Leeds includes weight-loss claims attached to named prescription medicines, urgency pressure, and before/after style marketing that a registered pharmacy should never publish.

None of this is an accusation against a named company, yet. Each finding is being documented with register entries, Companies House filings, archived screenshots and correspondence, and every finding will be published with that evidence linked. The GPhC's own register of fitness-to-practise outcomes and the MHRA's published enforcement actions show these are real problems regulators act on, not hypotheticals.

The ground rules, again

To be crystal clear: this page describes the tactics we are checking for and the categories of evidence being logged. It does not accuse any specific company. Where we find evidence, we'll publish it with the register entries, filings, screenshots and records linked, and the company named will get the right of reply before publication. Where we don't find evidence, nothing gets claimed. That's how this stays fair, and how it stays accurate.

Status

In progress: evidence gathering. Findings publish here when complete. This page was last updated 27 August 2026.

Help us investigate

Bought weight-loss medication from a company operating in Leeds? Charged fees that weren't advertised? Approved without a real consultation? Asked to leave a review for a discount? We want the detail: [email protected]. Meanwhile, the checks anyone can run in seconds are on our fake sites guide, verified providers serving Leeds are on our Leeds page, and the full verified list is in the directory.